삼성서울병원

Ko En
의료진 검색
찾으실 의료진명을 입력하여 검색해주세요.

비뇨의학과 전성수 교수

진료분야
전립선암, 로봇수술, PSA (전립선암 표지자) 이상소견
진료일정 12 月
날짜
수
01
목
02
금
03
토
04
일
05
월
06
화
07
수
08
목
09
금
10
토
11
일
12
월
13
화
14
수
15
목
16
금
17
토
18
일
19
월
20
화
21
수
22
목
23
금
24
토
25
일
26
월
27
화
28
수
29
목
30
금
31
오전
오후
진료일정 01 月
날짜
토
01
일
02
월
03
화
04
수
05
목
06
금
07
토
08
일
09
월
10
화
11
수
12
목
13
금
14
토
15
일
16
월
17
화
18
수
19
목
20
금
21
토
22
일
23
월
24
화
25
수
26
목
27
금
28
토
29
일
30
월
31
오전
오후
본원외래 본원클리닉 본원육아상담 암병원외래 암병원클리닉 암병원육아상담

학력

학력
2003.02 충북대학교 대학원 의학과(박사)
1996.02 서울대학교 의과대학원 의학사(석사)
1991.02 서울대학교 의과대학 졸업(의학사)
1987.02 서울대학교 자연대학 의예과

경력

경력
2021.04 ~현재 삼성서울병원 로봇수술센터장
2019.04 ~현재 삼성서울병원 비뇨의학과 과장 및 주임교수
2012.04 ~현재 삼성서울병원 비뇨의학과 교수
2015.04 ~ 2021.03 삼성서울병원 비뇨암센터 센터장
2006.04 ~ 2012.03 삼성서울병원 비뇨의학과 부교수
2006.07 ~ 2007.10 Univ of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School - Adjunct Assistant Professor
2006.05 ~ 2007.10 Cancer Institute of New Jersey - Research for Prostate Cancer
2002.04 ~ 2006.03 삼성서울병원 비뇨의학과 조교수
2000.03 ~ 2002.03 삼성서울병원 비뇨의학과 전임강사
1997.03 ~ 2000.02 삼성서울병원 비뇨의학과 전임의
1997.03 비뇨의학과 전문의 자격 취득
1993.03 ~ 1997.02 서울대학교병원 비뇨의학과 레지던트과정 수료
1991.03 ~ 1992.02 서울대학교병원 인턴과정 수료

학회활동

학회활동
2018.09 ~ 2020.12 대한비뇨기종양학회 회장
2013.02 ~ 2016.07 대한비뇨기종양학회 총무이사
2008.11 ~ 2010.10 대한비뇨의학회 학술위원회 이사
2008.08 ~ 2010.09 대한비뇨기종양학회 정보위원회 이사
2007.11 ~ 2009.10 비뇨기계기초의학연구회 정보상임이사
2007.11 ~ 2009.10 대한전립선학회 이사
2007.11 ~ 2009.10 대한내비뇨기학회 교육상임이사
2005.01 ~ 2006.04 대한비뇨의학회 정보이사
2003.11 ~ 2006.04 대한비뇨의학회 정보상임이사
논문
  • TECHNOL CANCER RES T 2021 10.1177/15330338211024660 Dr. Answer AI for Prostate Cancer: Predicting Biochemical Recurrence Following Radical Prostatectomy Park1, J; Rho, MJ; Moon, HW; Kim, J; Lee, C; Kim, D; Kim, CS; Jeon, SS; Kang, M; Lee, JY
    View PubMed
  • PLOS ONE 2021 10.1371/journal.pone.0249709 Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value Chung1, JH; Jeong, JY; Lee, JY; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-87573-5 Comparison of oncologic and functional outcomes between radical nephroureterectomy and segmental ureterectomy for upper urinary tract urothelial carcinoma Kim1, TH; Lee, CU; Kang, M; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Sung, HH
    View PubMed
  • BIOLOGY-BASEL 2021 10.3390/biology10040297 Assessment of Agreement between Two Difference Prostate-Specific Antigen Assay Modalities Chung1, JH; Park, M; Cho, H; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • PROSTATE INT 2021 10.1016/j.prnil.2020.06.003 Prostate cancer trajectory-map: clinical decision support system for prognosis management of radical prostatectomy Park1, J; Rho, MJ; Moon, HW; Park, YH; Kim, CS; Jeon, SS; Kang, M; Lee, JY
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-85099-4 Potential of circulating tumor DNA as a predictor of therapeutic responses to immune checkpoint blockades in metastatic renal cell carcinoma Kim1, YJ; Kang, Y; Kim, JS; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Park, D; Park, WY; Kang, M
    View PubMed
  • INVESTIG CLIN UROL 2021 10.4111/icu.20200406 Genomic mutation profiling using liquid biopsy in Korean patients with prostate cancer: Circulating tumor DNA mutation predicts the development of castration resistance Yu1, J; Cho, E; Choi, J; Lim, JE; Lee, J; Kang, M; Sung, HH; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • PLOS ONE 2020 10.1371/journal.pone.0244660 Risk of dementia and Parkinson's disease in patients treated with androgen deprivation therapy using gonadotropin-releasing hormone agonist for prostate cancer A nationwide population-based cohort study Shim1, M; Bang, WJ; Oh, CY; Lee, YS; Jeon, SS; Ahn, H; Ju, YS; Cho, JS
    View PubMed
  • INVESTIG CLIN UROL 2020 10.4111/icu.20200214 Docetaxel rechallenge in metastatic castration-resistant prostate cancer A retrospective, single-center study Byeon1, S; Kim, H; Kim, J; Kwon, M; Hur, JY; Jeon, HG; Jeon, SS; Lee, HM; Park, SH
    View PubMed
  • INVESTIG CLIN UROL 2020 10.4111/icu.20200084 Correlation between Gleason score distribution and Prostate Health Index in patients with prostate-specific antigen values of 2.5-10 ng/mL Choi1, J; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM
    View PubMed
  • J KOREAN MED SCI 2020 10.3346/jkms.2020.35.e342 Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL) Chung1, JH; Yu, J; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • FRONT ONCOL 2020 10.3389/fonc.2020.568809 Programmed Cell Death-Ligand 1 Expression Status in Urothelial Carcinoma According to Clinical and Pathological Factors A Multi-Institutional Retrospective Study Kim1, HS; Jang, WS; Ham, WS; Jung, SI; Lee, DH; Ku, JH; Ha, HK; Ku, JY; Choi, SY; Chang, IH; Choi, T; Song, W; Jeon, SS; Jeong, BC; Kim, SH; Seo, HK
    View PubMed
  • J CANCER 2020 10.7150/jca.48062 Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors A Propensity-Score Matching Analysis Kang1, M; Choi, J; Kim, J; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Park, SH; Song, C; Seo, SI
    View PubMed
  • PROSTATE INT 2020 10.1016/j.prnil.2020.03.003 Detection of prostate cancer using prostate imaging reporting and data system score and prostate-specific antigen density in biopsy-naive and prior biopsy-negative patients Ryoo1, H; Kang, MY; Sung, HH; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • INT J SURG 2020 10.1016/j.ijsu.2020.07.006 Relationship between robotic-assisted radical prostatectomy and retropubic radical prostatectomy in the learning curve of a single surgeon as a novice in radical prostatectomy A retrospective cohort study Song1, W; Lee, SW; Chung, JH; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • PLOS ONE 2020 10.1371/journal.pone.0236553 Dr. Answer AI for prostate cancer Clinical outcome prediction model and service Rho1, MJ; Park, J; Moon, HW; Lee, C; Nam, S; Kim, D; Kim, CS; Jeon, SS; Kane, M; Lee, JY
    View PubMed
  • DIS MARKERS 2020 10.1155/2020/8887605 Clinical Significance of Pre-to-Postoperative Dynamics of Aspartate Transaminase/Alanine Transaminase Ratio in Predicting the Prognosis of Renal Cell Carcinoma after Surgical Treatment Kang1, M; Shin, SJ; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Seo, SI
    View PubMed
  • CANCERS 2020 10.3390/cancers12040866 Integrative Radiogenomics Approach for Risk Assessment of Post-Operative Metastasis in Pathological T1 Renal Cell Carcinoma: A Pilot Retrospective Cohort Study Lee1, HW; Cho, HH; Joung, JG; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Nam, DH; Park, WY; Kim, CK; Seo, SI; Park, H
    View PubMed
  • J KOREAN MED SCI 2020 10.3346/jkms.2020.35.e47 The Use of Gonadotropin-Releasing Hormone Agonist Does Not Affect the Development of Cardiovascular Disease in Prostate Cancer Patients: a Nationwide Population-Based Cohort Study Shim1, M; Bang, WJ; Oh, CY; Lee, YS; Jeon, SS; Ahn, H; Ju, YS; Cho, JS
    View PubMed
  • INVESTIG CLIN UROL 2020 10.4111/icu.2020.61.1.19 Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting Jung1, SI; Kim, MS; Jeong, CW; Kwak, C; Hong, SK; Kang, SH; Joung, JY; Lee, SH; Yun, SJ; Kim, TH; Park, SW; Jeon, SS; Kang, M; Lee, JY; Chung, BH; Hong, JH; Ahn, H; Kim, CS; Kwon, DD
    View PubMed
  • CLIN GENITOURIN CANC 2019 10.1016/j.clgc.2019.07.014 Novel Predictive Models of Early Death Less Than 1 Year in Patients With Metastatic Renal Cell Carcinoma After Treatment With First-line Tyrosine Kinase Inhibitors Shin1, SJ; Kim, T; Sung, HH; Jeon, HG; Jeong, BC; Park, SH; Jeon, SS; Lee, HM; Choi, HY; Seo, SI; Kang, M
    View PubMed
  • J ENDOUROL 2019 10.1089/end.2019.0410 Comparison by Pentafecta Criteria of Transperitoneal and Retroperitoneal Robotic Partial Nephrectomy for Large Renal Tumors Choi1, CI; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Seo, SI
    View PubMed
  • INVESTIG CLIN UROL 2019 10.4111/icu.2019.60.6.454 The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy Song1, W; Kang, M; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.604 Atezolizumab in Patients with Pretreated Urothelial Cancer: A Korean Single-Center, Retrospective Study Hur1, JY; Kim, Y; Kwon, GY; Kang, M; Sung, HH; Jean, HG; Jeong, BC; Seo, SI; Jean, SS; Lee, HM; Lee, SJ; Park, SH
    View PubMed
  • UROL INT 2019 10.1159/000501527 Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy Lee1, CU; Sung, SH; Jang, CT; Kang, M; Sung, HH; Jeong, BC; Il Seo, S; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • WORLD J UROL 2019 10.1007/s00345-018-02617-2 Combination of multiparametric magnetic resonance imaging and transrectal ultrasound-guided prostate biopsies is not enough for identifying patients eligible for hemiablative focal therapy for prostate cancer Choi1, YH; Yu, JW; Kang, MY; Sung, HH; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • CUAJ-CAN UROL ASSOC 2019 10.5489/cuaj.5605 Detection of circulating tumor cells and their potential use as a biomarker for advanced renal cell carcinoma Kim1, TH; Kang, YT; Cho, YH; Kim, JH; Jeong, BC; Seo, SL; Jeon, SS; Lee, HM
    View PubMed
  • APPL SCI-BASEL 2019 10.3390/app9152982 PROMISE CLIP Project: A Retrospective, Multicenter Study for Prostate Cancer that Integrates Clinical, Imaging and Pathology Data Park1, J; Rho, MJ; Park, YH; Jung, CK; Chong, Y; Kim, CS; Go, H; Jeon, SS; Kang, M; Lee, HJ; Hwang, SI; Lee, JY
    View PubMed
  • INVESTIG CLIN UROL 2019 10.4111/icu.2019.60.4.227 Genomic analysis of Korean patients with advanced prostate cancer by use of a comprehensive next-generation sequencing panel and low-coverage, whole-genome sequencing Kang1, M; Cho, E; Jang, J; Lee, J; Jeon, Y; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Jeon, HG
    View PubMed
  • INT J SURG 2019 10.1016/j.ijsu.2019.04.013 Impact of adjuvant chemotherapy on oncologic outcomes following radical nephroureterectomy for patients with pT3NanyM0 upper tract urothelial carcinoma: A retrospective cohort study Song1, W; Jeong, JY; Jeon, HG; Seo, SI; Jeon, SS; Choi, HY; Lee, HM; Sung, HH
    View PubMed
  • BMC UROL 2019 10.1186/s12894-019-0463-7 A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naive prostate cancer Yoon1, SE; Kim, Y; Cho, J; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Lee, SJ; Park, SH
    View PubMed
  • PROSTATE 2019 10.1002/pros.23766 A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivation Choi1, YH; Han, DH; Kim, SW; Kim, MJ; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY
    View PubMed
  • Cancer Manag Res 2019 10.2147/CMAR.S199432 Predictors of postoperative complications after robot-assisted radical cystectomy with extracorporeal urinary diversion Lee1, CU; Kang, M; Kim, TJ; Na, JP; Sung, HH; Jeon, HG; Seo, S; Jeon, SS; Lee, HM; Jeong, BC
    View PubMed
  • SCI REP-UK 2019 10.1038/s41598-019-42739-0 Transperitoneal radical nephroureterectomy is associated with worse disease progression than retroperitoneal radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma Kim1, TH; Suh, YS; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Sung, HH
    View PubMed
  • PROSTATE CANCER P D 2019 10.1038/s41391-018-0088-z Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data Jeong1, CW; Kang, M; Jung, SI; Kim, TH; Park, SW; Joung, JY; Jeon, SS; Hong, JH; Lee, JY; Chung, BH; Ahn, H; Kim, CS; Kwon, DD; Kwak, C
    View PubMed
  • CLIN GENITOURIN CANC 2019 10.1016/j.clgc.2018.09.007 Comparison of Cancer Detection Rates Between TRUS-Guided Biopsy and MRI-Targeted Biopsy According to PSA Level in Biopsy-Naive Patients: A Propensity Score Matching Analysis Choi1, YH; Kang, MY; Sung, HH; Eon, HG; Jeong, BC; Seo, SI; Jeon, SS; Kim, CK; Park, BK; Lee, HM
    View PubMed
  • KOREAN J RADIOL 2019 10.3348/kjr.2018.0613 Prognostic Significance for Long-Term Outcomes Following Radical Prostatectomy in Men with Prostate Cancer: Evaluation with Prostate Imaging Reporting and Data System Version 2 Kim1, R; Kim, CK; Park, JJ; Kim, JH; Seo, SI; Jeon, SS; Lee, HM
    View PubMed
  • SCI REP-UK 2019 10.1038/s41598-018-36602-x Establishment and Validation of Extra-transitional Zone Prostate Specific Antigen Density (ETzD), a Novel Structure-based Parameter for Quantifying the Oncological Hazard of Prostates with Enlarged Stroma Kim1, JJ; Suh, YS; Kim, TH; Jeon, SS; Lee, HM; Choi, H; Kim, S; Lee, KS
    View PubMed
  • Cancer Manag Res 2019 10.2147/CMAR.S185796 Incidences and oncological outcomes of urothelial carcinoma in kidney transplant recipients Yu1, J; Lee, CU; Kang, M; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Sung, HH
    View PubMed
  • DIAGN PATHOL 2019 10.1186/s13000-019-0782-8 Histological characteristics of the largest and secondary tumors in radical prostatectomy specimens and implications for focal therapy Choi1, YH; Yu, JW; Jeong, BC; Seo, S; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • CLIN GENITOURIN CANC 2018 10.1016/j.clgc.2018.07.030 Oncologic Outcomes of Cytoreductive Nephrectomy in Synchronous Metastatic Renal-Cell Carcinoma: A Single-Center Experience Choi1, CI; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Seo, SIL
    View PubMed
  • J UROLOGY 2018 10.1016/j.juro.2018.06.030 Changeable Conditional Survival Rates and Associated Prognosticators in Patients with Metastatic Renal Cell Carcinoma Receiving First Line Targeted Therapy Kang1, M; Park, JY; Jeong, CW; Hwang, EC; Song, C; Hong, SH; Kwak, C; Chung, J; Sung, HH; Jeon, HG; Jeong, BC; Park, SH; Jeon, SS; Lee, HM; Choi, HY; Seo, SI
    View PubMed
  • CLIN GENITOURIN CANC 2018 10.1016/j.clgc.2018.02.015 Role of PI-RADS Version 2 for Prediction of Upgrading in Biopsy-Proven Prostate Cancer With Gleason Score 6 Song1, W; Bang, SH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Choi, HY; Kim, CK; Lee, HM
    View PubMed
  • EUR RADIOL 2018 10.1007/s00330-018-5305-6 RFA versus robotic partial nephrectomy for T1a renal cell carcinoma: a propensity score-matched comparison of mid-term outcome Park1, BK; Gong, IH; Kang, MY; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Seo, SI
    View PubMed
  • OncoTargets and therapy 2018 10.2147/OTT.S169094 The clinical usefulness of natural killer cell activity in patients with suspected or diagnosed prostate cancer: an observational cross-sectional study Song1, W; Yu, JW; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Kang, ES; Jeon, HG
    View PubMed
  • INT J UROL 2018 10.1111/iju.13574 Prognostic impact of the pretreatment aspartate transaminase/alanine transaminase ratio in patients treated with first-line systemic tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma Kang1, M; Yu, J; Sung, HH; Jeon, HG; Jeong, BC; Park, SH; Jeon, SS; Lee, HM; Choi, HY; Seo, SI
    View PubMed
  • J ENDOUROL 2018 10.1089/end.2017.0820 Long-Term Outcomes of Laparoendoscopic Single-Site Nephrolithotomy for Caliceal Diverticular Calculi: A Case Series Park1, BH; Han, CH; Chung, JD; Sung, HH; Jeong, BC; Jeon, SS; Han, DH
    View PubMed
  • TRANSL ONCOL 2018 10.1016/j.tranon.2017.10.008 Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract Lee1, JY; Kim, K; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Kwon, GY; Kim, KM; Lee, J; Lim, HY; Park, SH
    View PubMed
  • CANCER RES TREAT 2018 10.4143/crt.2016.477 Selection Criteria for Active Surveillance of Patients with Prostate Cancer in Korea: A Multicenter Analysis of Pathology after Radical Prostatectomy Jeong1, CW; Hong, SK; Byun, SS; Jeon, SS; Seo, SI; Lee, HM; Ahn, H; Kwon, DD; Ha, HK; Kwon, TG; Chung, JS; Kwak, C; Kim, HJ
    View PubMed
  • PLoS One 2018 10.1371/journal.pone.0191786 Comparisons of oncological outcomes and perioperative complications between laparoscopic and open radical nephrectomies in patients with clinical T2 renal cell carcinoma (>= 7cm) Lee1, H; Lee, CU; Yoo, JH; Sung, HH; Jeong, BC; Jeon, SS; Lee, HM; Choi, HY; Jeong, CW; Kwak, C; Il Seo, S
    View PubMed
  • ANN SURG ONCOL 2017 10.1245/s10434-017-6065-2 y Prognostic Significance of Pre- to Postoperative Dynamics of the Prognostic Nutritional Index for Patients with Renal Cell Carcinoma Who Underwent Radical Nephrectomy Kang1, M; Chang, CT; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Choi, HY; Lee, HM
    View PubMed
  • J ENDOUROL 2017 10.1089/end.2017.0369 Predictive Factors for Achieving Superior Pentafecta Outcomes Following Robot-Assisted Partial Nephrectomy in Patients with Localized Renal Cell Carcinoma Kang1, M; Gong, IH; Park, HJ; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Choi, HY; Seo, SI
    View PubMed
  • PLoS One 2017 10.1371/journal.pone.0186026 Comparative rates of upstaging and upgrading in Caucasian and Korean prostate cancer patients eligible for active surveillance Jeon1, HG; Yoo, JH; Jeong, BC; Seo, SI; Jeon, SS; Choi, HY; Lee, HM; Ferrari, M; Brooks, JD; Chung, BI
    View PubMed
  • J CANCER RES CLIN 2017 10.1007/s00432-017-2502-7 Impact of Gleason score on biochemical recurrence in patients with pT3aN0/Nx prostate cancer with positive surgical margins: a multicenter study from the Prostate Cancer Research Committee Song1, W; Lee, DH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Choi, HY; Kim, JW; Lee, S; Byun, SS; Jeong, CW; Kwak, C; Cho, JS; Ahn, H; Jeon, SS
    View PubMed
  • SURG ONCOL 2017 10.1016/j.suronc.2017.04.003 Endoscopic management of upper tract urothelial carcinoma: Improved prediction of invasive cancer using a ureteroscopic scoring model Jeon1, SS; Sung, HH; Jeon, HG; Han, DH; Jeong, BC; Seo, SI; Lee, HM; Choi, HY
    View PubMed
  • BMC UROL 2017 10.1186/s12894-017-0253-z A retrospective feasibility study of biweekly, reduced-dose docetaxel in Asian patients with castrate-resistant, metastatic prostate cancer Kim1, HS; Lee, JY; Lee, SJ; Lim, HY; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Park, SH
    View PubMed
  • Asian J Androl. 2017 May-Jun;19(3):346-349. doi: 10.4103/1008-682X.172826. Mutation of MED12 is not a frequent occurrence in, prostate cancer of Korean patients Yoon N11, Lim S1, Kang SY1, Kwon GY1, Jeon HG2, Jeong BC2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2.
    View PubMed
  • J Urol. 2017 Apr;197(4):991-997. doi: 10.1016/j.juro.2016.10.055. Epub 2016 Oct 17. Postoperative Outcome of Cystic Renal Cell Carcinoma Defined on Preoperative Imaging: A Retrospective Study Park JJ11, Jeong BC2, Kim CK3, Seo SI2, Carriere KC4, Kim M5, Park BK6, Jeon SS2, Lee HM2, Choi HY2.
    View PubMed
  • Sci Rep. 2017 Mar 6;7:39562. doi: 10.1038/srep39562. Comparison of bone mineral loss by combined androgen block agonist versus GnRH in patients with prostate cancer: A 12 month-prospective observational study Kim SH11, Joung JY1, Kim S1, Rha KH2, Kim HG3, Kwak C4, Lee JY5, Jeon SS6, Hong SK7, Jeong H8, Jo MK9, You D10, Jeong IG10, Hong JH10, Kim CS10.
    View PubMed
  • Urol Oncol. 2017 Mar;35(3):114.e1-114.e7. doi: 10.1016/j.urolonc.2016.10.022. Epub 2016 Nov 28. The effect of contralateral kidney volume on renal function after radical nephroureterectomy: Implications for eligibility for neoadjuvant chemotherapy for upper tract urothelial cancer Song W11, Sung HH1, Han DH1, Jeong BC1, Seo SI1, Jeon SS1, Lee HM1, Choi HY1, Jeon HG2.
    View PubMed
  • Int Urol Nephrol. 2017 Feb;49(2):191-196. doi: 10.1007/s11255-016-1458-x. Epub 2016 Nov 25. Clinical significance of incidentally detected bladder wall thickening on computed tomography Song W11, Jeon HG1, Jeong BC1, Seo SI1, Jeon SS1, Choi HY1, Lee HM2.
    View PubMed
  • Scand J Urol. 2017 Feb;51(1):27-32. doi: 10.1080/21681805.2016.1266384. Development of a new nomogram to predict insignificant prostate cancer in patients undergoing radical prostatectomy Kim TH11, Jeon HG2, Jeong BC2, Seo SI2, Jeon SS2, Choi HY2, Lee HM2.
    View PubMed
  • Asian J Androl. 2017 Jan-Feb;19(1):20-25. doi: 10.4103/1008-682X.159715. Refining the American Urological Association and American Society for Radiation Oncology guideline for adjuvant radiotherapy after radical prostatectomy using the pathologic Gleason score Song W11,2, Kwon YS1, Jeon SS2, Kim IY1.
    View PubMed
  • Oncotarget. 2016 Dec 13;7(50):83735-83743. doi: 10.18632/oncotarget.13407. Immunohistochemical staining of ERG and SOX9 as potential biomarkers of docetaxel response in patients with metastatic castration-resistant prostate cancer Song W11, Kwon GY2, Kim JH3, Lim JE4, Jeon HG1, Il Seo S1, Jeon SS1, Choi HY1, Jeong BC1, Lee HM1.
    View PubMed
  • Can Urol Assoc J. 2016 Nov-Dec;10(11-12):E377-E382. doi: 10.5489/cuaj.3896. Epub 2016 Nov 10. Relationship between Gleason score and apparent diffusion coefficients of diffusion-weighted magnetic resonance imaging in prostate cancer patients Kim TH11, Kim CK2, Park BK2, Jeon HG3, Jeong BC3, Seo SI3, Lee HM3, Choi HY3, Jeon SS3.
    View PubMed
  • Oncotarget. 2016 Sep 27;7(39):63870-63886. doi: 10.18632/oncotarget.11563. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2 Park BH11, Lim JE2, Jeon HG3, Seo SI3, Lee HM3, Choi HY3, Jeon SS3, Jeong BC3.
    View PubMed
  • Oncotarget. 2016 Aug 9;7(32):51626-51639. doi: 10.18632/oncotarget.10539. Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletion Chang N11,2,3, Lee HW3,4, Lim JE5, Jeong DE1, Song HJ6, Kim S3,7, Nam DH1,2,3, Sung HH5, Jeong BC5, Seo SI5, Jeon SS5, Lee HM5, Choi HY5, Jeon HG5.
    View PubMed
  • Yonsei Med J. 2016 Jul;57(4):855-64. doi: 10.3349/ymj.2016.57.4.855. Prognostic Factors for Recurrence and Progression in Korean Non-Muscle-Invasive Bladder Cancer Patients: A Retrospective, Multi-Institutional Study Kim HS11, Ku JH2, Kim SJ3, Hong SJ4, Hong SH5, Kim HS6, Kwon TG7, Cho JS8, Jeon SS9, Joo KJ10, Ahn HJ11, Park HS12, Seong do H13, Kwon DD14, Kim HJ15, Lim JS16, Lee HL17.
    View PubMed
  • J Endourol. 2016 Jul;30(7):783-91. doi: 10.1089/end.2015.0652. Epub 2016 May 26. Oncological Outcomes in Patients Treated with Radical Cystectomy for Bladder Cancer: Comparison Between Open, Laparoscopic, and Robot-Assisted Approaches Kim TH11, Sung HH2, Jeon HG2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2, Jeong BC2.
    View PubMed
  • J Clin Pathol. 2016 Jul;69(7):586-92. doi: 10.1136/jclinpath-2015-203314. Epub 2015 Dec 15. Correlation of ERG immunohistochemistry with molecular detection of TMPRSS2-ERG gene fusion Sung JY11, Jeon HG2, Jeong BC2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2, Kang SY3, Choi YL3, Kwon GY3.
    View PubMed
  • Int J Urol. 2016 Jun;23(6):472-7. doi: 10.1111/iju.13077. Epub 2016 Mar 14. Comparison of preoperative adaptive enlargement of the contralateral normal kidney in patients nephrectomized for benign non-functioning kidney versus renal cell carcinoma Song W11, Sung HH1, Han DH1, Jeong BC1, Seo SI1, Jeon SS1, Lee HM1, Choi HY1, Jeon HG1.
    View PubMed
  • Int Urol Nephrol. 2016 Jun;48(6):977-83. doi: 10.1007/s11255-016-1250-y. Epub 2016 Feb 26. Tumor size is associated with compensatory hypertrophy in the contralateral kidney after radical nephrectomy in patients with renal cell carcinoma Park BH11, Sung HH2, Jeong BC2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2, Jeon HG3.
    View PubMed
  • J Urol. 2016 May;195(5):1464-70. doi: 10.1016/j.juro.2015.11.031. Epub 2015 Dec 1. Pathological Outcome following Radical Prostatectomy in Men with Prostate Specific Antigen Greater than 10 ng/ml and Histologically Favorable Risk Prostate Cancer Yu J11, Kwon YS2, Kim S2, Han CS3, Farber N3, Kim J3, Byun SS4, Kim WJ5, Jeon SS6, Kim IY7.
    View PubMed
  • UROLOGY, APR 2016, 90:124-125, DOI: 10.1016/j.urology.2015.10.053 Size and Volumetric Growth Kinetics of Renal Masses in Patients With Renal Cell Carcinoma REPLY Lee SW1, Il Seo S
    View PubMed
  • Urology. 2016 Apr;90:119-24. doi: 10.1016/j.urology.2015.10.051. Epub 2016 Jan 11. Size and Volumetric Growth Kinetics of Renal Masses in Patients With Renal Cell Carcinoma Lee SW11, Sung HH1, Jeon HG1, Jeong BC1, Jeon SS1, Lee HM1, Choi HY1, Seo SI2.
    View PubMed
  • J Urol. 2016 Mar;195(3):568-73. doi: 10.1016/j.juro.2015.09.073. Epub 2015 Sep 26. Percutaneous Kidney Biopsy for a Small Renal Mass: A Critical Appraisal of Results Jeon HG11, Seo SI1, Jeong BC1, Jeon SS1, Lee HM1, Choi HY1, Song C1, Hong JH1, Kim CS1, Ahn H1, Jeong IG2.
    View PubMed
  • World J Urol. 2016 Jan;34(1):63-8. doi: 10.1007/s00345-015-1551-2. Epub 2015 Apr 3. Volumetric measurement of compensatory hypertrophy in the contralateral normal kidney by the tumor growth Park BH11, Jeong BC2, Jeon SS2, Seo SI2, Lee HM2, Choi HY2, Jeon HG3.
    View PubMed
  • World J Urol. 2016 Jan;34(1):83-8. doi: 10.1007/s00345-015-1592-6. Epub 2015 May 17. The impact of three-dimensional tumor volume on cancer-specific survival for patients with pT1 clear-cell renal cell carcinoma Song W11, Jeong BC1, Seo SI1, Jeon SS1, Lee HM1, Choi HY1, Jeon HG2.
    View PubMed
  • Int J Urol. 2016 Jan;23(1):56-61. doi: 10.1111/iju.12960. Epub 2015 Oct 26. Prognostic factors after salvage radiotherapy alone in patients with biochemical recurrence after radical prostatectomy Song W11, Jeon HG1, Sung HH1, Jeong BC1, Seo SI1, Jeon SS1, Choi HY1, Lee HM1.
    View PubMed
  • Ann Surg Oncol. 2016 Jan;23(1):321-7. doi: 10.1245/s10434-015-4614-0. Epub 2015 Jun 5. Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival in Renal Cell Carcinoma Patients Undergoing Nephrectomy Jeon HG11, Choi DK1, Sung HH1, Jeong BC1, Seo SI1, Jeon SS1, Choi HY1, Lee HM2.
    View PubMed
  • Eur Radiol. 2015 Nov;25(11):3143-50. doi: 10.1007/s00330-015-3741-0. Epub 2015 May 8. Measurement of renal function in a kidney donor: a comparison of creatinine-based and volume-based GFRs Choi DK11, Choi SM1, Park BH2, Jeong BC1, Seo SI1, Jeon SS1, Lee HM1, Choi HY1, Jeon HG3.
    View PubMed
  • PLoS One. 2015 Nov 24;10(11):e0141709. doi: 10.1371/journal.pone.0141709. eCollection 2015. Trends in the Use of Nephron-Sparing Surgery over 7 Years: An Analysis Using the RENAL Nephrometry Scoring System Shin SJ11, Ko KJ1, Kim TS1, Ryoo HS1, Sung HH1, Jeon HG1, Jeong BC1, Seo SI1, Lee HM1, Choi HY1, Jeon SS1.
    View PubMed
  • J Korean Med Sci. 2015 Nov;30(11):1631-7. doi: 10.3346/jkms.2015.30.11.1631. Epub 2015 Oct 16. Is Radical Perineal Prostatectomy a Viable Therapeutic Option for Intermediate- and High-risk Prostate Cancer Lee HW11, Jeon HG2, Jeong BC2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2.
    View PubMed
  • PLoS One. 2015 Nov 10;10(11):e0139976. doi: 10.1371/journal.pone.0139976. eCollection 2015. Diagnostic Ureterorenoscopy Is Associated with Increased Intravesical Recurrence following Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma Sung HH11, Jeon HG1, Han DH1, Jeong BC1, Seo SI1, Lee HM1, Choi HY1, Jeon SS1.
    View PubMed
  • Oncotarget. 2015 Oct 20;6(32):33046-64. doi: 10.18632/oncotarget.5422. Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis Jeong da E11, Song HJ2, Lim S3, Lee SJ4, Lim JE5, Nam DH1,4,6, Joo KM1,2, Jeong BC5, Jeon SS5, Choi HY5, Lee HW4,7.
    View PubMed
  • J Urol. 2015 Oct;194(4):910-5. doi: 10.1016/j.juro.2015.04.093. Epub 2015 Apr 28. Compensatory Structural and Functional Adaptation after Radical Nephrectomy for Renal Cell Carcinoma According to Preoperative Stage of Chronic Kidney Disease Choi DK11, Jung SB1, Park BH1, Jeong BC1, Seo SI1, Jeon SS1, Lee HM1, Choi HY1, Jeon HG2.
    View PubMed
  • J Korean Med Sci. 2015 Sep;30(9):1321-7. doi: 10.3346/jkms.2015.30.9.1321. Epub 2015 Aug 13. Diagnostic and Prognostic Significance of Radiologic Node-positive Renal Cell Carcinoma in the Absence of Distant Metastases: A Retrospective Analysis of Patients Undergoing Nephrectomy and Lymph Node Dissection Lee HW11, Jeon HG2, Jeong BC2, Seo SI2, Jeon SS2, Choi HY2, Lee HM2.
    View PubMed
  • BMC Urol. 2015 Aug 1;15:79. doi: 10.1186/s12894-015-0070-1. Oncologic outcomes in men with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institution international study Kwon YS11, Ha YS2,3, Modi PK4, Salmasi A5, Parihar JS6, Patel N7, Faiena I8, May M9, Lee DI10, Llukani E11, Patrick T12, Rha KH13, Ahlering T14, Skarecky D15, Ahn H16, Choi SK17, Park S18, Jeon SS19, Ou YC20, Eun D21, Manucha V22, Albala D23, Badani K24, Yuh B25, Ruel N26, Kim TH27, Kwon TG28, Marchalik D29, Hwang J30, Kim WJ31, Kim IY32.
    View PubMed
  • Int Neurourol J. 2015 Jun;19(2):113-9. doi: 10.5213/inj.2015.19.2.113. Epub 2015 Jun 29. Effect of Continuous Urethro-Vesical Anastomosis Technique in Incontinence After Radical Retropubic Prostatectomy, 1:1 Matching Study Lee SW11, Han DH1, Lee KS1, Jeon SS1.
    View PubMed
  • Eur Radiol. 2015 Jun;25(6):1786-92. doi: 10.1007/s00330-014-3566-2. Epub 2015 Jan 31. Diffusion-weighted magnetic resonance imaging for prediction of insignificant prostate cancer in potential candidates for active surveillance Kim TH11, Jeong JY, Lee SW, Kim CK, Park BK, Sung HH, Jeon HG, Jeong BC, Seo SI, Lee HM, Choi HY, Jeon SS.
    View PubMed
  • Int J Urol. 2015 May;22(5):455-61. doi: 10.1111/iju.12716. Epub 2015 Jan 29. Prognostic significance of visceral obesity in patients with advanced renal cell carcinoma undergoing nephrectomy Lee HW11, Jeong BC, Seo SI, Jeon SS, Lee HM, Choi HY, Jeon HG.
    View PubMed
  • BJU Int. 2015 Apr;115(4):587-94. doi: 10.1111/bju.12846. Epub 2014 Dec 7. Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma Sung HH11, Jeon HG, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM.
    View PubMed
  • Abdom Imaging. 2015 Mar;40(3):571-7. doi: 10.1007/s00261-014-0245-3. Comparison of re-biopsy with preceded MRI and re-biopsy without preceded MRI in patients with previous negative biopsy and persistently high PSA Park BK11, Jeon SS, Park B, Park JJ, Kim CK, Lee HM, Choi HY.
    View PubMed
  • PLoS One. 2015 Mar 23;10(3):e0122019. doi: 10.1371/journal.pone.0122019. eCollection 2015. A Comparison of Radiologic Tumor Volume and Pathologic Tumor Volume in Renal Cell Carcinoma (RCC) Choi SM11, Choi DK2, Kim TH2, Jeong BC2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2, Jeon HG3.
    View PubMed
  • J Korean Med Sci. 2015 Mar;30(3):317-22. doi: 10.3346/jkms.2015.30.3.317. Epub 2015 Feb 16. Comparison of Pathological and Biochemical Outcomes after Radical Prostatectomy in Korean Patients with Serum PSA Ranges Lee HW11, Jeon HG1, Jeong BC1, Seo SI1, Jeon SS1, Choi HY1, Lee HM1.
    View PubMed
  • Int J Urol. 2015 Jan;22(1):82-7. doi: 10.1111/iju.12604. Epub 2014 Sep 10. Significance of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgery Chang JH11, Park W, Park JS, Pyo H, Huh SJ, Choi HY, Lee HM, Jeon SS, Seo SI.
    View PubMed
  • J Korean Med Sci. 2014 Dec;29(12):1688-93. doi: 10.3346/jkms.2014.29.12.1688. Epub 2014 Nov 21. Interval from Prostate Biopsy to Radical Prostatectomy Does Not Affect Immediate Operative Outcomes for Open or Minimally Invasive Approach Park B11, Choo SH2, Jeon HG3, Jeong BC3, Seo SI3, Jeon SS3, Lee HM3, Choi HY3.
    View PubMed
  • World J Urol. 2014 Dec;32(6):1523-9. doi: 10.1007/s00345-014-1312-7. Epub 2014 May 10. Transperitoneal versus retroperitoneal robotic partial nephrectomy: matched-pair comparisons by nephrometry scores Choo SH11, Lee SY, Sung HH, Jeon HG, Jeong BC, Jeon SS, Lee HM, Choi HY, Seo SI.
    View PubMed
  • Urology. 2014 Nov;84(5):1001-7. doi: 10.1016/j.urology.2014.06.052. Epub 2014 Oct 24. Incidence and Management of Extended-spectrum Beta-lactamase and Quinolone-resistant Escherichia coli Infections After Prostate Biopsy Song W11, Choo SH1, Sung HH1, Han DH1, Jeong BC1, Seo SI1, Jeon SS1, Lee KS1, Lee SW1, Lee HM1, Choi HY1, Jeon HG2.
    View PubMed
  • J Urol. 2014 Oct;192(4):1064-71. doi: 10.1016/j.juro.2014.04.001. Epub 2014 Apr 13. Reassessment of Prognostic Heterogeneity of pT3 Renal Pelvic Urothelial Carcinoma: Analysis in Terms of Proposed pT3 Subclassification Systems Park J11, Habuchi T2, Arai Y3, Ohyama C4, Inoue T2, Hatakeyama S4, Jeon SS5, Kwon GY6, Kwak C7, Moon KC8, Kim CS9, Ahn H10.
    View PubMed
  • J Urol.?2014 Jul;192(1):82-8. doi: 10.1016/j.juro.2014.01.005. Epub 2014 Jan 15. Influence of Magnetic Resonance Imaging in the Decision to Preserve or Resect Neurovascular Bundles at Robotic Assisted Laparoscopic Radical Prostatectomy Park BH11,?Jeon HG1,?Jeong BC1,?Seo SI1,?Lee HM1,?Choi HY1,?Jeon SS2.
    View PubMed
  • BJU Int. 2014 Jun;113(6):864-70. doi: 10.1111/bju.12423. Epub 2013 Dec 2. Role of multiparametric 3.0-Tesla magnetic resonance imaging in patients with prostate cancer eligible for active surveillance Park BH11, Jeon HG, Choo SH, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM.
    View PubMed
  • Int J Urol. 2014 Apr;21(4):377-81. doi: 10.1111/iju.12326. Epub 2013 Oct 29. Pathological upgrading and upstaging of patients eligible for active surveillance according to currently used protocols Kim TH11, Jeon HG, Choo SH, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM.
    View PubMed
  • Radiother Oncol. 2014 Feb;110(2):240-4. doi: 10.1016/j.radonc.2014.01.001. Epub 2014 Jan 28. Suggestion for the prostatic fossa clinical target volume in adjuvant or salvage radiotherapy after a radical prostatectomy Park JS11, Park W2, Pyo HR1, Park BK3, Park SY3, Choi HY4, Lee HM4, Jeon SS4, Seo SI4, Jeong BC4, Jeon HG4.
    View PubMed
  • Urol Oncol. 2014 Jan;32(1):49.e23-31. doi: 10.1016/j.urolonc.2013.07.015. FGFR3 overexpression is prognostic of adverse outcome for muscle-invasive bladder carcinoma treated with adjuvant chemotherapy Sung JY11, Sun JM2, Chang Jeong B3, Il Seo S3, Soo Jeon S3, Moo Lee H3, Yong Choi H3, Young Kang S4, Choi YL5, Young Kwon G6.
    View PubMed
  • J Clin Pathol. 2014 Jan;67(1):49-54. doi: 10.1136/jclinpath-2013-201799. Epub 2013 Aug 12. Clinical significance of micropapillary urothelial carcinoma of the upper urinary tract Sung HH11, Cho J, Kwon GY, Jeon HG, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM.
    View PubMed
  • Eur J Cancer. 2014 Jan;50(1):64-9. doi: 10.1016/j.ejca.2013.08.018. Epub 2013 Sep 20. Small tumour size is associated with new-onset chronic kidney disease after radical nephrectomy in patients with renal cell carcinoma Jeon HG11, Choo SH1, Sung HH1, Jeong BC1, Seo SI1, Jeon SS1, Choi HY1, Lee HM2.
    View PubMed
  • Oncology. 2013;85(5):299-305. doi: 10.1159/000355689. Epub 2013 Nov 6. Cross-Cultural Application of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Prostate Cancer - EORTC QLQ-PR25 Park J11, Shin DW, Yun SJ, Park SW, Jeon SS, Kwak C, Kwon TG, Kim HJ, Ahn H.
    View PubMed
  • Asian J Androl.?2013 Mar;15(2):236-40. doi: 10.1038/aja.2012.123. Epub 2012 Dec 31. Detection rate of clinically insignificant prostate cancer increases with repeat prostate biopsies Park B11,?Jeon SS,?Ju SH,?Jeong BC,?Seo SI,?Lee HM,?Choi HY.
    View PubMed
  • Int J Cancer. 2013 Feb 1;132(3):625-34. doi: 10.1002/ijc.27639. Epub 2012 Jun 20. Body mass index and survival in patients with renal cell carcinoma: A clinical-based cohort and meta-analysis Choi Y11, Park B, Jeong BC, Seo SI, Jeon SS, Choi HY, Adami HO, Lee JE, Lee HM.
    View PubMed
  • J Endourol. 2012 Oct;26(10):1290-5. doi: 10.1089/end.2012.0117. Epub 2012 Sep 24. Independent Predictors of Recovery of Continence 3 Months After Robot-Assisted Laparoscopic Radical Prostatectomy Kim JJ11, Ha YS, Kim JH, Jeon SS, Lee DH, Kim WJ, Kim IY.
    View PubMed
  • Cancer Causes Control.?2012 Mar;23(3):505-11. doi: 10.1007/s10552-012-9910-4. Epub 2012 Feb 19. Impact of body mass index in Korean patients with renal cell carcinoma Sung HH11,?Jeon SS,?Park SY,?Jeong BC,?Seo SI,?Lee HM,?Choi HY.
    View PubMed
  • Prostate. 2011 Oct 1;71(14):1525-37. doi: 10.1002/pros.21369. Epub 2011 Mar 3. Macrophages Induce Neuroendocrine Differentiation of Prostate Cancer Cells Via BMP6-IL6 Loop Lee GT11, Kwon SJ, Lee JH, Jeon SS, Jang KT, Choi HY, Lee HM, Kim WJ, Lee DH, Kim IY.
    View PubMed
  • Urology.?2011 Apr;77(4):1013-4; author reply 1014. doi: 10.1016/j.urology.2010.11.051. Re: Kim et al.: Detection Rates of Nonpalpable Prostate Cancer in Korean Men With Prostate-specific Antigen Levels Between 2.5 and 4.0 ng/mL (Urology 2010;76:919-922) Reply Shenoy SP1,?Marla PK,?Adappa KK.
    View PubMed
  • J?Korean?Med Sci.?2011 Mar;26(3):360-4. doi: 10.3346/jkms.2011.26.3.360. Epub 2011 Feb 25. Incidence and Predictive Factors of Benign Renal Lesions in Korean Patients with Preoperative Imaging Diagnoses of Renal Cell Carcinoma Park SY11,?Jeon SS,?Lee SY,?Jeong BC,?Seo SI,?Lee HM,?Choi HY.
    View PubMed
  • J Biol Chem. 2010 Dec 10;285(50):39401-8. doi: 10.1074/jbc.M110.103705. Epub 2010 Oct 1. Induction of Interleukin-6 Expression by Bone Morphogenetic Protein-6 in Macrophages Requires Both SMAD and p38 Signaling Pathways Lee GT11, Kwon SJ, Lee JH, Jeon SS, Jang KT, Choi HY, Lee HM, Kim WJ, Kim SJ, Kim IY.
    View PubMed
  • Urology.?2010 Oct;76(4):919-22. doi: 10.1016/j.urology.2009.12.036. Epub 2010 Mar 29. Detection Rates of Nonpalpable Prostate Cancer in Korean Men With Prostate-specific Antigen Levels Between 2.5 and 4.0 ng/mL Kim HS11,?Jeon SS,?Choi JD,?Kim W,?Han DH,?Jeong BC,?Seo SI,?Lee KS,?Lee SW,?Lee HM,?Choi HY.
    View PubMed
  • J Endourol. 2009 Sep;23(9):1485-9. doi: 10.1089/end.2009.0375. Comparison of Hand-Assisted Laparoscopic Radical Nephrectomy with Open Radical Nephrectomy for pT1-2 Clear Cell Renal-Cell Carcinoma: A Multi-Institutional Study Park YH11, Byun SS, Kang SH, Koh JS, Park HK, Paick SH, Seo YJ, Yoo TG, Jung H, Cho JS, Jeon SS, Choi Y, Park SK.
    View PubMed
  • J Endourol.?2008 Sep;22(9):1937-9; discussion 1941-2. doi: 10.1089/end.2008.9773. Laparoscopic Partial Nephrectomy without Hilar Control Jeon SS11,?Kim IY.
    View PubMed
  • J Endourol.?2007 Aug;21(8):906-10. Determination of ideal Stent length for endourologic surgery Jeon SS11,?Choi YS,?Hong JH.
    View PubMed
  • Int J Urol.?2005 Jun;12(6):544-7. A comparison of holmium : YAG laser with Lithoclast lithotripsy in ureteral calculi fragmentation Jeon SS11,?Hyun JH,?Lee KS.
    View PubMed
  • Urol Res. 2004 Dec;32(6):416-20. Epub 2004 Oct 14. Clinical features determining the fate of a long-term, indwelling, forgotten double J stents Park K11, Jeon SS, Park H, Kim HH.
    View PubMed
  • Urology. 2003 Sep;62(3):461-6. Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy Jeon SS11, Woo SH, Hyun JH, Choi HY, Chai SE.
    View PubMed
  • ASAIO J. 2002 Sep-Oct;48(5):460-4. Effect of different particles on cell proliferation in polymer scaffolds using a solvent-casting and particulate leaching technique Suh SW11, Shin JY, Kim J, Kim J, Beak CH, Kim DI, Kim H, Jeon SS, Choo IW.
    View PubMed
  • J Endourol. 2001 Sep;15(7):753-9. Diagnostic efficacy of fluorescence cystoscopy for detection of urothelial neoplasms Jeon SS11, Kang I, Hong JH, Choi HY, Chai SE.
    View PubMed
  • Korean J Radiol. 2001 Jan-Mar;2(1):14-20. Unenhanced spiral CT in acute ureteral colic: A replacement for excretory urography Ryu JA11, Kim B, Jeon YH, Lee J, Lee JW, Jeon SS, Park KH.
    View PubMed